Last Published 02.01.2026 Effective Date: 01.01.2026 This policy addresses sacral nerve stimulation for urinary and fecal indications
Eur J Nucl Med Mol Imaging 48:28232833 Guntur VP, Nemkov T, de Boer E, Mohning MP, Baraghoshi D, Cendali FI, San-Millan I, Petrache I, DAlessandro A (2022) Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of Covid-19 (PASC)
These programs also include medical oversight and, in many cases, lifestyle support to make progress sustainable
However, the drugs alterations in gut motility may account for many of their commonly reported adverse effects including nausea, vomiting, early satiety, dyspepsia, and bowel habit changes